What Is the Average Weekly Weight Loss on Zepbound?

Last reviewed: July 7, 2026

Last updated: July 7, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide, marketed as Zepbound for weight loss, activates two hormone pathways that regulate appetite and blood sugar—the GLP-1 receptor and the GIP receptor. Clinical trials show participants lose an average of 15–22% of body weight over 68 weeks, but individual weekly loss varies significantly based on dose, lifestyle, and genetic predisposition. Understanding realistic expectations helps you set achievable goals and stay motivated throughout your treatment journey.

What Do Clinical Trials Show About Weekly Weight Loss on Tirzepatide?

The SURMOUNT trials, which led to Zepbound's approval, tracked participants over 68 weeks. Those taking the highest dose of tirzepatide lost an average of 22% of baseline body weight—roughly 52 pounds for someone starting at 235 pounds. This translates to approximately 0.75 pounds per week on average, though the pace is faster during the first 12 weeks and slower as the body adapts.

Participants in the placebo group lost only 2.4% of body weight, highlighting that tirzepatide's dual-receptor action produces results far beyond diet and exercise alone. The medication's peak weight loss occurs between weeks 12 and 32, after which the rate of loss typically slows as your body reaches a new equilibrium. Most users notice the greatest changes in the first three months when weekly loss can reach 1–1.5 pounds.

It's important to note that 'average' masks individual variation. Some patients lose 2 pounds weekly during early phases, while others lose 0.3 pounds weekly. This variation depends on starting weight, metabolic rate, medication adherence, diet quality, and genetic factors that affect how efficiently your body responds to GLP-1 and GIP activation.

How Genetic Factors Influence Your Personal Weight Loss Rate

Your genetic blueprint shapes how effectively tirzepatide works for you. Variants in GIPR gene (rs1800437) directly influence how sensitively your appetite-control receptors respond to the medication. People with certain genetic variants may experience faster appetite suppression and weight loss, while others may need dose optimization or alternative approaches.

PlexusDx Precision Peptide Genetic Test analyzes 14 metabolic pathways and 150+ genetic insights, including key markers like FTO rs9939609 (fat storage predisposition) and MC4R rs17782313 (energy regulation). By mapping your peptide pathway genetics before or during early treatment, PlexusDx identifies whether you're a fast responder, moderate responder, or someone who may benefit from a dual-compound strategy like GLP-Squared. This precision approach transforms weight loss from guesswork into personalized science.

Genetic testing costs $298, allowing you to start therapy immediately while gathering data to fine-tune your protocol. With these insights, your PlexusDx provider can adjust your medication choice, dose, or treatment timeline to match your genetic responsiveness.

Weekly Weight Loss Phases: What to Expect Month by Month

Month 1 (Weeks 1–4): Most users experience rapid appetite suppression and mild gastrointestinal adjustment. Weekly weight loss averages 0.5–1 pound as your body begins responding to the medication. Some of this initial loss is water weight, which is normal and expected.

Months 2–3 (Weeks 5–12): This is the acceleration phase. Weekly weight loss often peaks at 1–1.5 pounds as the medication reaches steady state and dose titration reaches therapeutic levels. Nausea and appetite changes plateau, making adherence easier. Many people report noticeable clothes fitting looser and increased energy.

Months 4–6 (Weeks 13–24): Weight loss continues but at a more moderate pace of 0.5–1 pound weekly. Your body adapts to the medication, and hunger signals begin returning slightly as your system finds a new baseline. Maintaining consistent diet quality and physical activity becomes more important during this phase.

How PlexusDx Personalizes Tirzepatide Treatment for Maximum Results

PlexusDx offers compounded tirzepatide injection at $289/mo month-to-month, or from $249/mo on the 6-month plan—equivalent to brand-name pricing but with personalization built in. Because PlexusDx uses licensed 503A compounding pharmacies, your medication is manufactured specifically for your prescription, not mass-produced. This allows for precise dose adjustments that match your genetic responsiveness and clinical needs.

Your dose may need to go up—your price won't. PlexusDx's flat-rate pricing means whether your provider increases your tirzepatide dose from 2.5 mg to 15 mg, your monthly cost remains $289/month. This removes the financial barrier to optimal dosing and ensures you receive the dose that works best for your body, not the dose your budget allows.

PlexusDx also offers oral tirzepatide ($349/month) and GLP-Squared injection ($289/month), a dual-compound combining semaglutide and tirzepatide for patients who need multi-pathway activation. HSA and FSA funds cover all PlexusDx medications, and treatment is available in all 50 states without insurance or membership fees. Your provider monitors your weekly weight loss, adjusts your protocol based on response, and uses genetic insights to prevent plateaus.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Is 1 pound per week realistic on tirzepatide?

Yes, 1 pound weekly is realistic during the first 8–12 weeks for many patients, especially those starting at higher body weights. However, this pace typically slows after 3 months as your metabolism adapts. PlexusDx providers track your individual trajectory and adjust treatment to sustain steady progress without burnout or side effects.

What if I'm not losing 1 pound per week—am I a non-responder?

Not necessarily. Losing 0.5 pounds weekly is still healthy, sustainable weight loss and aligns with clinical trial averages. If your loss is slower than expected, PlexusDx can recommend genetic testing to identify whether you'd benefit from dose optimization, switching to tirzepatide if you're on semaglutide, or adding a dual-compound like GLP-Squared.

How much does tirzepatide cost at PlexusDx, and does price change with dose?

Compounded tirzepatide injection is $289/mo month-to-month (or $249/mo on the 6-month plan) and remains flat across all dose levels—your dose may need to go up, but your price won't. PlexusDx also offers oral tirzepatide at $349/mo (or $279/mo on the 6-month plan), and both are HSA/FSA eligible. No insurance or membership is required, and treatment ships to all 50 states.

What are common side effects that might slow my weight loss?

Nausea, constipation, and reduced appetite are common in the first 2–4 weeks and often improve with time. These side effects don't prevent weight loss—they're part of how the medication works. If side effects become intolerable, your PlexusDx provider can adjust your dose, switch medications, or recommend supportive strategies. Serious side effects are rare.

How does the Precision Peptide Genetic Test improve my weight loss results?

PlexusDx's $298 genetic test analyzes your GIPR, FTO, and MC4R variants among 150+ insights across 14 pathways. Results reveal whether you're genetically predisposed to fast GLP-1 response, high fat storage, or blunted satiety signaling. Your provider uses this data to choose the right medication, dose, or dual-compound strategy, turning guesswork into precision medicine.

Related Reading

• Average Weight Loss On Ozempic
• Wegovy Vs Zepbound Weight Loss
• Zepbound For Weight Loss
• Maxlife Weight Loss

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.